Skip to Content
Course

Drug Metabolism

BIOL-40170

Approximately one out of every 1,000 compounds identified in preclinical studies is eventually found suitable for human use. This creates a need to shorten the time and cost to increase the "hit" rate of finding drug candidates. This course will give you a comprehensive understanding of the biochemical aspects of drug metabolism in the drug discovery process and related pharmaceutical principles. Topics include pharmacokinetics, Phase I and II drug metabolism, factors affecting drug metabolism, and recent advances in drug metabolizing and absorption technology. The goal of this course is to give students a full appreciation of the drug metabolism aspects of the NDA process as well as an ability to predict drug metabolism and distribution of new chemical entities.

Course Information

Online
3.00 units
$725.00

Course sessions

Add To Cart

Section ID:

187904

Class type:

Online Asynchronous.

This course is entirely web-based and to be completed asynchronously between the published course start and end dates. Synchronous attendance is NOT required.
You will have access to your online course on the published start date OR 1 business day after your enrollment is confirmed if you enroll on or after the published start date.

Textbooks:

All course materials are included unless otherwise stated.

Policies:

  • No refunds after: 4/14/2025

Schedule:

No information available at this time.
Add To Cart

Instructor: Lisa Cordes

Lisa Cordes
Dr. Lisa Cordes has over a decade of clinical pharmacology experience and is an educator for multidisciplinary audiences. She earned her BS in Pharmaceutical Sciences from North Dakota State University and her Doctor of Pharmacy degree from the Medical University of South Carolina. Dr. Cordes began her career in clinical care and became board-certified in both ambulatory care and oncology. She has designed and directed global educational offerings in pharmacology and research. Dr. Cordes has served as an investigator on over 50 clinical trials and is an advisor throughout the drug development process, from concept review to publication. Her areas of interest include clinical pharmacology and oncology clinical research.
 
Full Bio